HOB Biotech Group Corp.,Ltd (SHA:688656)

SHA:688656 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	94.16	121.63	163.47	153.8	449.86	58.82
Trading Asset Securities	-	-	-	135.23	5.01	-
Cash & Short-Term Investments	94.16	121.63	163.47	289.03	454.87	58.82
Cash Growth	-20.46%	-25.60%	-43.44%	-36.46%	673.38%	-35.20%
Accounts Receivable	41.44	48.61	41.5	32.38	37.48	29.9
Other Receivables	1.78	2.41	3.94	5.54	3.66	1.39
Receivables	43.22	51.02	45.44	37.92	41.15	31.29
Inventory	114.94	111.22	111.22	87.8	68.2	61.95
Prepaid Expenses	-	-	-	-	-	0.14
Other Current Assets	10.92	8.25	8.09	8.23	5.75	6.46
Total Current Assets	263.24	292.12	328.21	422.98	569.97	158.65
Property, Plant & Equipment	699.59	705.71	578.68	485.27	259.74	119.97
Other Intangible Assets	9.94	10.08	11.86	12.59	12.17	11.29
Long-Term Accounts Receivable	-	-	0.05	0.1	0.62	1.45
Long-Term Deferred Tax Assets	3.74	4.13	2.47	1.78	1.63	0.97
Long-Term Deferred Charges	15.28	12.12	11.58	16.25	10.27	2
Other Long-Term Assets	11.65	8.65	16.4	5.52	9.52	2.08
Total Assets	1,003	1,033	949.26	944.49	863.92	296.41
Accounts Payable	24.45	44.59	23.91	9.37	9.37	6.25
Accrued Expenses	8.48	37.98	34.98	31.06	29.4	22.34
Short-Term Debt	105.06	105.07	50.02	50.01	20.02	20.02
Current Portion of Leases	-	1.1	4.8	5.67	5.51	-
Current Income Taxes Payable	8.48	3.33	4.67	1.53	2.33	-
Current Unearned Revenue	13.51	14.45	14.62	13.33	13.54	9.08
Other Current Liabilities	8.95	3.42	2.74	41.89	6.01	5.53
Total Current Liabilities	168.93	209.94	135.75	152.86	86.17	63.23
Long-Term Debt	16	8	-	-	-	23.98
Long-Term Leases	1.86	1.53	1.03	9.74	5.35	-
Long-Term Unearned Revenue	1.82	1.2	1.74	2.49	2.4	2.81
Long-Term Deferred Tax Liabilities	-	-	-	0.04	0	-
Total Liabilities	188.61	220.67	138.52	165.13	93.92	90.02
Common Stock	63.06	63.06	63.06	63.06	63.06	47.29
Additional Paid-In Capital	564.03	562.98	553.46	550.62	549.35	68.65
Retained Earnings	207.46	205.82	193.92	165.51	157.49	90.32
Treasury Stock	-20.01	-20.01	-	-	-	-
Comprehensive Income & Other	0.29	0.29	0.29	0.18	0.1	0.13
Shareholders' Equity	814.83	812.14	810.73	779.36	770	206.39
Total Liabilities & Equity	1,003	1,033	949.26	944.49	863.92	296.41
Total Debt	122.93	115.69	55.86	65.43	30.88	44
Net Cash (Debt)	-28.77	5.93	107.61	223.6	423.99	14.81
Net Cash Growth	-	-94.49%	-51.88%	-47.26%	2762.22%	-63.59%
Net Cash Per Share	-0.47	0.09	1.68	3.54	6.89	0.31
Filing Date Shares Outstanding	62.26	62.26	62.72	63.06	63.06	47.29
Total Common Shares Outstanding	62.26	62.26	63.06	63.06	63.06	47.29
Working Capital	94.31	82.18	192.46	270.12	483.8	95.43
Book Value Per Share	13.09	13.04	12.86	12.36	12.21	4.36
Tangible Book Value	804.89	802.06	798.87	766.77	757.83	195.1
Tangible Book Value Per Share	12.93	12.88	12.67	12.16	12.02	4.13
Buildings	-	1.25	20.53	20.53	17.34	17.34
Machinery	-	848.29	249.06	214.57	167.93	126.92
Construction In Progress	-	4.83	422.97	325.75	128.88	24.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.